TVRD
Tvardi Therapeutics, Inc.
-0.02 (-1.16%)1.71USD55.8K成交股數22.8M市值42.8本益比(近四季)3.0股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 2.6M+20% | 1.5M-70% | 2.6M-63% | 991K-84% | 2.1M | 4.9M | 6.9M | 6.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.0M | 4.9M | 3.6M | 5.8M | 3.1M | −9.6M | 4.8M | 6.5M | 22.0M | 25.5M | 30.3M | 24.3M |
| 銷售管理費用 | 2.6M | 2.1M | 2.3M | 3.1M | 1.2M | −3.9M | 881K | 650K | 6.8M | 6.8M | 7.5M | 6.9M |
| 營業利益 | −6.6M+52% | −7.1M-149% | −5.9M+5% | −8.9M+24% | −4.4M-85% | 14.4M-150% | −5.7M-82% | −7.2M-74% | −29.7M | −28.9M | −32.3M | −27.7M |
| 營業利益率 | – | – | – | – | -169.5% | 990.8% | -222.1% | -724.6% | -1,389.5% | -593.9% | -466.5% | -448.5% |
| 稅後淨利 | −6.5M-33% | −6.8M-46% | −5.5M+0% | 4.2M-160% | −9.6M+128% | −12.7M-55% | −5.5M-82% | −7.0M-74% | −4.2M | −28.0M | −31.5M | −26.7M |
| 淨利率 | – | – | – | – | -372.9% | -873.5% | -215.7% | -703.8% | -196.8% | -576.1% | -454.0% | -432.5% |
| 稀釋 EPS | -0.69-81% | -0.73-105% | -0.59-72% | -1.00-63% | -3.72-82% | 13.67-2729% | -2.14+269% | -2.71+453% | -20.24 | -0.52 | -0.58 | -0.49 |
| 稀釋股數 | 9.4M | 9.4M | 9.4M | 8.5M | 2.6M | 2.6M | 2.6M | 2.6M | 1.5M | 54.2M | 54.0M | 53.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 15.8M | 19.9M | 21.4M | 20.6M | 34.2M | 31.6M | 37.1M | 49.2M | 47.0M | 62.9M | 58.2M | 47.4M |
| 應收帳款 | – | – | – | – | 1.2M | 407K | 435K | 359K | 1.7M | 3.4M | – | – |
| 存貨 | – | – | – | – | 900K | 900K | 625K | 1.6M | 2.7M | 3.3M | 3.4M | 3.5M |
| 總資產 | 17.5M | 25.8M | 39.0M | 43.8M | 38.9M | 35.2M | 51.3M | 72.5M | 90.1M | 115M | 134M | 153M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.1M | 11.3M | 11.2M | 10.8M | 47.0M | 40.8M | 50.6M | 60.9M | 60.3M | – | – | – |
| 股東權益 | 8.4M | 14.5M | 27.9M | 32.9M | −101M | −91.1M | −78.5M | −73.1M | −66.2M | 85.6M | 109M | 137M |
| 負債比 | 52.1% | 43.8% | 28.6% | 24.7% | 120.7% | 116.0% | 98.6% | 84.0% | 66.9% | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.9M | – | – | −7.7M-75% | – | – | – | −30.5M | – | – | −34.6M |
| 資本支出 | – | – | – | – | – | – | – | – | 836K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −31.3M | – | – | – |
| 折舊攤銷 | – | 24K | – | – | 24K | – | – | – | 42K | – | – | 58K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -1,465.5% | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2024 年度 · 11.5M
| Other Revenue | 4.3M | 37.7% | +519.0% |
|---|---|---|---|
| Other Revenue Non Cash | 4.3M | 37.7% | +519.0% |
| Collaborative Revenue | 2.1M | 18.2% | -83.9% |
| Commercial Supply Revenue | 640K | 5.6% | -89.0% |
| Clinical Compound Revenue | 84K | 0.7% | -49.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −18.2M | –% | -3.26 | – |
| FY2024 | 7.1M | -66.0% | −29.4M | -411.9% | -11.42 | −19.4M |
| FY2023 | 21.0M | -49.9% | −11.9M | -56.5% | -26.26 | −94.5M |
| FY2022 | 41.9M | +81.8% | −85.5M | -204.2% | -19.12 | −78.8M |
| FY2021 | 23.0M | -83.0% | −88.4M | -384.1% | -1.74 | −60.1M |
| FY2020 | 135M | +579.3% | 8.4M | 6.2% | 0.18 | −5.8M |
| FY2019 | 19.9M | +47.6% | −106M | -534.9% | -2.49 | −109M |
| FY2018 | 13.5M | – | −74.0M | -549.5% | -2.06 | −22.4M |